Ken Law

Ken Law has a diverse work experience in the fields of analytical development, quality, CMC, and immunology. Ken held roles at companies like LEXEO Therapeutics and Rocket Pharmaceuticals, where they served as a Senior Director and Associate Director, respectively. Ken also worked as a scientist and senior research technologist in academic institutions like Icahn School of Medicine and Ragon Institute. Additionally, they managed a specialized histopathology/imaging core lab at Brigham and Women's Hospital.

Ken Law earned a Bachelor of Science in Biochemistry from the University of Wisconsin-Madison in 2006. Ken later achieved a Doctor of Philosophy (Ph.D.) in Immunology from the Icahn School of Medicine at Mount Sinai in 2016.